| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 5,615.28× | 5,615.28× | 3,462.87× | 3,496.31× | 2,607.23× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 35.13× | 35.13× | 27.56× | 40.22× | 44.65× | ||
| 365.11× | 365.11× | 234.36× | 717.89× | 986.54× | ||
| 5,285.30× | 5,285.30× | 3,256.07× | 2,818.64× | 1,665.34× | ||
| 0.39× | 0.31× | 0.28× | 0.31× | 0.35× | ||
| 0.07× | 0.07× | 0.11× | 0.10× | 0.11× | ||
| −1.07× | −1.07× | −1.61× | −0.93× | −4.61× | ||
| 4.71× | 4.71× | −50.55× | 5.34× | −11.55× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Inventory Days (DIO) | 2,607.23 | 3,496.31 | 3,462.87 | 5,615.28 | 5,615.28 | |
| Receivable Days (DSO) | 44.65 | 40.22 | 27.56 | 35.13 | 35.13 | |
| Payable Days (DPO) | 986.54 | 717.89 | 234.36 | 365.11 | 365.11 | |
| Cash Conversion Cycle (days) | 1,665.34 | 2,818.64 | 3,256.07 | 5,285.30 | 5,285.30 | |
| Working Capital Turnover | 0.35 | 0.31 | 0.28 | 0.31 | 0.39 | |
| Asset Turnover | 0.11 | 0.10 | 0.11 | 0.07 | 0.07 | |
| Cash Conversion (CFO/Net Income) | -4.61 | -0.93 | -1.61 | -1.07 | -1.07 | |
| CFO/EBITDA | -11.55 | 5.34 | -50.55 | 4.71 | 4.71 |